Analysts Think Axsome Therapeutics Stock Could Soar 35% Over the Next 12 Months. Is the Stock a No-Brainer Buy?
Or are its best days in the rearview mirror?
Market News
What the wires are covering — grouped by story, scored for tone
Previous-day view · Fri Sep 18 close.
You are previewing the previous trading day. Subscribe to see today live and every other
date — plans start at Delta, $39/mo.
Sign up
Sign in
Reading Sep 18's tape
Sep 18
Axsome Therapeutics vs. Moderna: Which Healthcare Stock Is a Better Buy in 2026?
One company is growing a commercial drug business with limited margin for error on the path to profitability. The other has a platform that proved itself at global scale and keeps finding new diseases to target.
Sep 18
994 storiesToday reads warmer than 0 of the last 5 scored days. Click a bar to read that day's stories.